Results 231 to 240 of about 107,636 (348)

Insights into Euphorbia diversity: Probing the contrasts between Euphorbia fischeriana Steud and Euphorbia ebracteolata Hayata

Journal of Pharmaceutical Analysis
Kaicheng Du, Yi Zhang, Lei Sun, Muke Tao, Tiantian Zuo, Yumeng Wang, Zhengfeng Zhang, Dali Meng   +7 more
doaj   +1 more source

Do psychotropic drugs cause seizures? [PDF]

Epilepsy Behav Rep
Gopaul M, Altalib H.
europepmc   +1 more source

Therapeutic drug monitoring of psychotropic medications

, 2000
Philip B. Mitchell
openalex   +1 more source

The Recruitment and Retention of Individuals With Intellectual Disability in Randomized Controlled Trials: A Scoping Review

British Journal of Learning Disabilities, EarlyView.
ABSTRACT Background People with intellectual disabilities face significant health disparities and often encounter barriers in accessing healthcare services. Although research supports the need for reasonable adjustments to improve healthcare access for this population, implementation in acute healthcare settings remains limited.
Owen Doody, Louise Murphy, Ruth Ryan, Rosemary Lyons, Wenyi Tang, Lorna Bourke   +5 more
wiley   +1 more source

Contribution of Human Hepatic Cytochrome P450 Isoforms to the Metabolism of Psychotropic Drugs

, 2005
Toshiro Niwa, Toshifumi Shiraga, Ikuko Ishii, Akira Kagayama, Akira Takagi   +4 more
openalex   +2 more sources

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source

The Australia story: Current status and future challenges for the clinical applications of psychedelics

British Journal of Pharmacology, EarlyView.
Abstract The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4‐methylenedioxymethamphetamine (MDMA), which have revealed great potential for treating mental health conditions. Given this progress in research, as well as the current unmet clinical need of millions of patients, in 2023, the Australian Therapeutic ...
David J Nutt, Peter Hunt, Anne Katrin Schlag, Paul Fitzgerald   +3 more
wiley   +1 more source

Maternal mental disorders, psychotropic drugs, socioeconomic status, and offspring congenital anomalies. [PDF]

J Int Med Res
Björkstedt SM, Koponen H, Kautiainen H, Gissler M M, Pennanen P, Eriksson JG, Laine MK.   +6 more
europepmc   +1 more source

Main legal bases related to the prescription and use of stupefacients, psychotropic drugs, and other toxicants in Cuba

, 2006
Héctor Barreiro Ramos, Alfredo Tamame Camargo, Niurka Lora Fajardo, Esperanza Ramírez Agüero   +3 more
openalex   +1 more source

Ocular Adverse Effects of Psychotropic Drugs: A Clinical Study of 20 Cases (2023–2025)

Z. Filali, H. Boui, H. Lazaar, L.O. Cherkaoui   +3 more
openalex   +1 more source